The Dangers of Ozempic, Wegovy, Rybelsus, and Other Weight Loss Drugs Ozempic, Wegovy, Rybelsus, manufactured by Novo Nordisk, as well as similar weight loss drugs like Mounjaro and Trulicity, manufactured by Eli Lilly and Company, carry potentially serious health risks
In clinical practice, treatment may be guided by dominant cardiometabolic phenotype, with early combination therapy considered in individuals at high risk or with overlapping disease domains
10.1016/j.mad.2006.11.016 Mech Ageing Dev
That's 70 pounds gone, but it's more than just the number

Essentially, Ipamorelin is the short-term trigger for the pituitary to release growth hormone, whereas the CJC-1295 is a much longer-term trigger (with raised hormone levels for as much as 6 to 10 days after administration) The Benifits CJC1295 Increased levels of energy, and better energy metabolism, with decreased fatigue Decreased body fat More easily maintained existing muscle mass, and increased ease to gain new lean muscle mass Higher rates of cellular repair, replication, and regeneration, making it easier to heal from injuries and boosting the immune system Greater bone mineral content, which can be effective at offsetting or decreasing the risk of osteoporosis Improved sleep quality Ipamorelin Increased levels of energy, and better energy metabolism, with decreased fatigue Decreased body fat More easily maintained existing muscle mass, and increased ease to gain new lean muscle mass Higher rates of cellular repair, replication, and regeneration, making it easier to heal from injuries and boosting the immune system Greater bone mineral content, which can be effective at offsetting or decreasing the risk of osteoporosis Improved sleep quality
